glp 1 agonist meds Top GLP-1 Agonists Balance Weight Loss Efficacy, Safety Comparing Ozempic, Wegovy and Other

52 In a phase 1b trial done to evaluate the safety, pharmacokinetics and pharmacodynamics of orforglipron in patients with T2DM, orforglipron resulted in significant reductions in HbA1c, fasting blood glucose and body weight, with an adverse event profile consistent with that of other GLP-1RA

Early studies show up to 13% body weight reduction in three months

Reduce or eliminate processed foods, excess added sugars, and vegetable oils

GLP-1/GIP medications do not: reduce central pain amplification correct nervous-system hypersensitivity treat neuropathic pain reverse joint degeneration Some patients feel better simply because weight loss improves sleep, mobility, energy, and moodnot because the medication treats fibromyalgia biology

Here are the approved uses for the four main GLP-1s: Mounjaro and Zepbound These are the two brands of tirzepatide

The GLP-1 receptor agonist liraglutide (brand name Saxenda) was FDA-approved for chronic weight management in 2014